Related Experiment Video

Updated: May 16, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

The future of targeted therapies for pediatric central nervous system tumors

Holly Lindsay1, Eric Bouffet2

  • 1Center for Cancer and Blood Disorders, Children's Hospital Colorado Anschutz Medical Campus, University of Colorado School of Medicine, Denver, Colorado, USA.

Neuro-Oncology Advances
|May 15, 2026
PubMed

Insights

Targeted therapies are revolutionizing pediatric brain tumor treatment, offering personalized strategies with fewer side effects. This review explores ongoing research for novel drugs and improved management of various pediatric brain tumors.

Area of Science:

  • Pediatric Neuro-Oncology
  • Translational Cancer Research

Background:

  • Pediatric brain tumors represent a significant challenge in oncology.
  • Current treatments often involve aggressive therapies with substantial long-term side effects.
  • The advent of targeted therapies presents a promising new avenue for treatment.

Purpose of the Study:

  • To review the current landscape of targeted therapies in pediatric neuro-oncology.
  • To summarize ongoing research into novel drug development for pediatric brain tumors.
  • To discuss improvements in managing specific pediatric brain tumor types.

Main Methods:

  • Literature review of recent clinical trials and preclinical studies.
  • Analysis of targeted therapy approaches for various pediatric brain tumor subtypes.
  • Synthesis of data on efficacy, safety, and personalized treatment strategies.

Main Results:

  • Targeted therapies demonstrate potential for increased efficacy and reduced toxicity.
  • Personalized treatment strategies are emerging based on molecular profiling.
  • Ongoing research focuses on novel agents and combination therapies.

Conclusions:

  • Targeted therapies are transforming pediatric brain tumor management.
  • Further research is crucial to optimize drug development and treatment protocols.
  • Improved outcomes and quality of life are anticipated with advanced targeted treatments.
Keywords:
BRAFH3K27MNTRKpediatric central nervous system tumorstargeted treatments

More Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice

Published on: February 24, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...